News on Cerus from BioPortfolio.com http://www.BioPortfolio.com Consolidated Cerus news from BioPortfolio.com Wed, 10 Feb 2010 06:10:32 GMT en Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035399&HITNO=0&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035399&THISHREF=http://c.moreover.com/click/here.pl%3fz2536227096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035399&HITNO=0&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035399&THISHREF=http://c.moreover.com/click/here.pl%3fz2536227096%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037028&HITNO=1&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037028&THISHREF=http://c.moreover.com/click/here.pl%3fz2536861147%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037028&HITNO=1&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037028&THISHREF=http://c.moreover.com/click/here.pl%3fz2536861147%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036942&HITNO=2&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036942&THISHREF=http://c.moreover.com/click/here.pl%3fz2536838131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036942&HITNO=2&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036942&THISHREF=http://c.moreover.com/click/here.pl%3fz2536838131%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Cerus Corporation Reports Positive Outcome Of Phase 1 Clinical Trial Of INTERCEPT Red Blood Cellshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037774&HITNO=3&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037774&THISHREF=http://c.moreover.com/click/here.pl%3fz2537281761%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037774&HITNO=3&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037774&THISHREF=http://c.moreover.com/click/here.pl%3fz2537281761%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cellshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036889&HITNO=4&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036889&THISHREF=http://c.moreover.com/click/here.pl%3fz2536815148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036889&HITNO=4&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036889&THISHREF=http://c.moreover.com/click/here.pl%3fz2536815148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Phase 1 trial of Cerus' INTERCEPT red blood system meets primary endpointhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036677&HITNO=5&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036677&THISHREF=http://c.moreover.com/click/here.pl%3fz2536701866%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036677&HITNO=5&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036677&THISHREF=http://c.moreover.com/click/here.pl%3fz2536701866%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cellshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034060&HITNO=6&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034060&THISHREF=http://c.moreover.com/click/here.pl%3fz2535590011%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034060&HITNO=6&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034060&THISHREF=http://c.moreover.com/click/here.pl%3fz2535590011%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Cerus' INTERCEPT red blood cells Phase 1 trial meets primary endpointhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033483&HITNO=7&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033483&THISHREF=http://c.moreover.com/click/here.pl%3fz2535229083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033483&HITNO=7&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033483&THISHREF=http://c.moreover.com/click/here.pl%3fz2535229083%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cellshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032873&HITNO=8&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032873&THISHREF=http://c.moreover.com/click/here.pl%3fz2534843064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032873&HITNO=8&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032873&THISHREF=http://c.moreover.com/click/here.pl%3fz2534843064%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Cerus to Collaborate with French National Transfusion Service on INTERCEPT Red Blood Cell Developmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035798&HITNO=9&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035798&THISHREF=http://c.moreover.com/click/here.pl%3fz2536377435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035798&HITNO=9&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035798&THISHREF=http://c.moreover.com/click/here.pl%3fz2536377435%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Medical News: Cerus Corporation Reports Positive Outcome Of Phase 1 Clinical Trial Of INTERCEPT Red Blood Cellshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038342&HITNO=10&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038342&THISHREF=http://c.moreover.com/click/here.pl%3fz2537571536%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038342&HITNO=10&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038342&THISHREF=http://c.moreover.com/click/here.pl%3fz2537571536%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Trial yields positive results for Cerus blood systemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037090&HITNO=11&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037090&THISHREF=http://c.moreover.com/click/here.pl%3fz2536903038%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037090&HITNO=11&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037090&THISHREF=http://c.moreover.com/click/here.pl%3fz2536903038%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Tuesday's biggest gaining and declining stockshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035071&HITNO=12&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035071&THISHREF=http://c.moreover.com/click/here.pl%3fz2536108154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035071&HITNO=12&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035071&THISHREF=http://c.moreover.com/click/here.pl%3fz2536108154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Cerus to Release Fourth Quarter and Year-End 2009 Results on February 23, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014046&HITNO=13&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014046&THISHREF=http://c.moreover.com/click/here.pl%3fz2523875020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4014046&HITNO=13&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4014046&THISHREF=http://c.moreover.com/click/here.pl%3fz2523875020%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Cerus to Release Fourth Quarter and Year-End 2009 Results on February 23, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017520&HITNO=14&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017520&THISHREF=http://c.moreover.com/click/here.pl%3fz2525176472%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017520&HITNO=14&MSIZE=45&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Cerus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017520&THISHREF=http://c.moreover.com/click/here.pl%3fz2525176472%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: